In a regulatory filing, the company states: “On February 25, 2026, Douglas Ingram notified Sarepta (SRPT) Therapeutics, Inc. of his decision to retire as Chief Executive Officer by the end of 2026 or upon the appointment of his replacement. The Company has commenced a search of internal and external candidates for Mr. Ingram’s replacement.”
Claim 30% Off TipRanks
Forget margin or options. Here's how the pros trade SRPTPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT: